Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls (rSIG)

Stanford University

Status and phase: Completed; Phase 1

Conditions: Healthy Controls

Treatments: Drug: [18F]-FTC-146

Study type: Interventional

Funder types: Other

Identifiers

NCT03649555

45678

Details and patient eligibility

About

The purpose of this study is to understand the reliability of [18F]-FTC-146 brain uptake in healthy controls.

Full description

The purpose of this study is to understand the reliability of [18F]-FTC-146 brain uptake in healthy controls under test and retest conditions.

Enrollment: 5 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. ages 18-65
2. either gender and all ethno-racial categories
3. capacity to provide informed consent
4. Female participants are expected to use an effective method of birth control throughout the study

Exclusion criteria

1. Any current or lifetime psychiatric diagnosis
2. Current or past use of psychotropic medication
3. Pregnant or nursing females
4. Major medical or neurological problem
5. Presence of metal in the body that is contraindicated for MRI scans

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

5 participants in 1 patient group

[18F]-FTC-146

Experimental group

Description:

\[18F\]-FTC-146

Treatment:

Drug: [18F]-FTC-146